Yj. Jeon et al., Acetylaminofluorene inhibits nitric oxide production in LPS-stimulated RAW264.7 cells by blocking NF-kappa B/Rel activation, TOX LETT, 104(3), 1999, pp. 195-202
The mechanism by which 2-acetylaminofluorene (AAF) inhibited nitric oxide (
NO) formation, in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells was i
nvestigated. The decrease in NO, as demonstrated by measurement of nitrite
was found to correlate well with a decrease in inducible nitric oxide synth
ase (iNOS) mRNA. Since the promoter in iNOS gene contains binding motifs fo
r NF-kappa B/Rel, AP-1, and NF-IL6 which appear to be important for LPS-med
iated iNOS induction, the effect of AAF on the activation of these transcri
ption factors was determined. Treatment of AAF to RAW 264.7 cells induced a
dose-related inhibition of NF-kappa B/IRel in chloramphenicol acetyltransf
erase activity, while either AP-1 or NF-IL6 activation was not affected by
AAF. Treatment of RAW 264.7 cells with AAF inhibited protein/DNA binding of
NF-kappa B/Rel to its cognate site as measured by electrophoretic mobility
shift assay. In addition, AAF treatment caused a significant reduction of
nuclear c-rel, p65, and p50 protein levels, and this decrease was parallele
d by the accumulation of cytoplasmic c-rel, p65, and p50. These data sugges
t that AAF inhibits iNOS gene expression by a mechanism involving a blockad
e of LPS-induced nuclear translocation of NF-kappa B/Rel. (C) 1999 Elsevier
Science Ireland Ltd. All rights reserved.